NO20092469L - Azasykloalkanderivater som inhibitorer av stearoyl-koenzym A-delta-9-desaturase - Google Patents
Azasykloalkanderivater som inhibitorer av stearoyl-koenzym A-delta-9-desaturaseInfo
- Publication number
- NO20092469L NO20092469L NO20092469A NO20092469A NO20092469L NO 20092469 L NO20092469 L NO 20092469L NO 20092469 A NO20092469 A NO 20092469A NO 20092469 A NO20092469 A NO 20092469A NO 20092469 L NO20092469 L NO 20092469L
- Authority
- NO
- Norway
- Prior art keywords
- desaturase
- delta
- coenzyme
- inhibitors
- azacycloalkane derivatives
- Prior art date
Links
- 239000005515 coenzyme Substances 0.000 title abstract 3
- 150000003976 azacycloalkanes Chemical class 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 title 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 208000004930 Fatty Liver Diseases 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 102100028897 Stearoyl-CoA desaturase Human genes 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87221606P | 2006-12-01 | 2006-12-01 | |
| US89890007P | 2007-02-01 | 2007-02-01 | |
| PCT/CA2007/002139 WO2008064474A1 (en) | 2006-12-01 | 2007-11-28 | Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20092469L true NO20092469L (no) | 2009-08-27 |
Family
ID=39467388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20092469A NO20092469L (no) | 2006-12-01 | 2009-06-30 | Azasykloalkanderivater som inhibitorer av stearoyl-koenzym A-delta-9-desaturase |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8063224B2 (pt) |
| EP (1) | EP2099793B1 (pt) |
| JP (1) | JP5050061B2 (pt) |
| KR (1) | KR20090086623A (pt) |
| AR (1) | AR064026A1 (pt) |
| AT (1) | ATE543816T1 (pt) |
| AU (1) | AU2007327276B2 (pt) |
| BR (1) | BRPI0719702A2 (pt) |
| CA (1) | CA2670703C (pt) |
| CL (1) | CL2007003440A1 (pt) |
| CO (1) | CO6190521A2 (pt) |
| CR (1) | CR10858A (pt) |
| EA (1) | EA200970524A1 (pt) |
| EC (1) | ECSP099375A (pt) |
| GT (1) | GT200900144A (pt) |
| IL (1) | IL198824A0 (pt) |
| MA (1) | MA31017B1 (pt) |
| MX (1) | MX2009005713A (pt) |
| NO (1) | NO20092469L (pt) |
| PE (1) | PE20081199A1 (pt) |
| SV (1) | SV2009003275A (pt) |
| TN (1) | TN2009000212A1 (pt) |
| TW (1) | TW200826936A (pt) |
| WO (1) | WO2008064474A1 (pt) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1315831E (pt) * | 2000-02-24 | 2010-11-04 | Xenon Pharmaceuticals Inc | Estearoil-coa dessaturase para identificar agentes terapêuticos que reduzem triglicéridos |
| CA2651700A1 (en) * | 2006-05-22 | 2007-11-29 | Merck Frosst Canada Ltd. | Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| JP2009539884A (ja) * | 2006-06-12 | 2009-11-19 | メルク フロスト カナダ リミテツド | ステアロイル−コエンザイムａデルタ−９デサチュラーゼのインヒビターとしてのアゼチジン誘導体 |
| US7754745B2 (en) | 2006-06-13 | 2010-07-13 | Merck Frosst Canada Ltd. | Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| US20090318476A1 (en) * | 2006-08-09 | 2009-12-24 | Merck Frosst Canada Ltd. | Azacycloalkane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase |
| AR064965A1 (es) | 2007-01-26 | 2009-05-06 | Merck Frosst Canada Inc | Derivados de azacicloalcanos como inhibidores de estearoil - coenzima a delta -9 desaturasa |
| WO2008128335A1 (en) * | 2007-04-20 | 2008-10-30 | Merck Frosst Canada Ltd. | Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| AU2008253512A1 (en) * | 2007-05-23 | 2008-11-27 | Merck Frosst Canada Ltd. | Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
| US7842696B2 (en) | 2007-06-21 | 2010-11-30 | Forest Laboratories Holdings Limited | Piperazine derivatives as inhibitors of stearoyl-CoA desaturase |
| AR067557A1 (es) * | 2007-07-19 | 2009-10-14 | Takeda Pharmaceutical | Preparacion solida y metodo de preparacion |
| AU2008280784A1 (en) * | 2007-07-20 | 2009-01-29 | Merck Frosst Canada Ltd | Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| CA2735794A1 (en) * | 2008-09-08 | 2010-03-11 | Merck Frosst Canada Ltd. | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| JP5597210B2 (ja) * | 2009-02-17 | 2014-10-01 | メルク カナダ インコーポレイテッド | ステアロイル−補酵素ａデルタ−９デサチュラーゼの阻害剤として有用な新規スピロ化合物 |
| AU2010215041A1 (en) * | 2009-02-23 | 2011-07-28 | Merck Canada Inc. | Heterocyclic derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
| WO2010108268A1 (en) * | 2009-03-23 | 2010-09-30 | Merck Frosst Canada Ltd. | Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| US8383643B2 (en) | 2009-07-28 | 2013-02-26 | Merck Canada Inc. | Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
| ES2613066T3 (es) | 2010-04-28 | 2017-05-22 | Bayer Intellectual Property Gmbh | Derivados de cetoheteroarilpiperidina y -piperazina como fungicidas |
| CN103476771B (zh) * | 2011-01-28 | 2015-12-23 | 4Sc探索有限责任公司 | 用于治疗自身免疫炎症的IL17和IFN-γ抑制 |
| MX2014004426A (es) | 2011-10-15 | 2014-07-09 | Genentech Inc | Metodos de uso de antagonistas de scd1. |
| WO2013062882A1 (en) * | 2011-10-26 | 2013-05-02 | Merck Canada Inc. | Scd inhibitors for the treatment of hcv |
| WO2013134546A1 (en) | 2012-03-07 | 2013-09-12 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| JP6293127B2 (ja) | 2012-05-22 | 2018-03-14 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド | 未分化細胞の選択的阻害剤 |
| WO2016022955A1 (en) | 2014-08-07 | 2016-02-11 | Mayo Foundation For Medical Education And Research | Compounds and methods for treating cancer |
| MA46589A (fr) | 2016-10-24 | 2019-08-28 | Yumanity Therapeutics Inc | Composés et utilisations de ces derniers |
| EP3566055B1 (en) | 2017-01-06 | 2025-03-12 | Janssen Pharmaceutica NV | Scd inhibitor for the treatment of neurological disorders |
| CA3083000A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| ES3043183T3 (en) | 2018-03-23 | 2025-11-25 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| MX2021008903A (es) | 2019-01-24 | 2021-11-04 | Yumanity Therapeutics Inc | Compuestos y usos de los mismos. |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1595923A1 (de) * | 1965-02-20 | 1969-11-27 | Merck Ag E | 1-Aralkyl-4-(thiazolyl-2)-piperazine und Verfahren zu ihrer Herstellung |
| CA2237273C (en) | 1996-01-15 | 2009-01-13 | Janssen Pharmaceutica N.V. | Angiogenesis inhibiting pyridazinamines |
| US20050119251A1 (en) | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
| US7754711B2 (en) | 2003-07-30 | 2010-07-13 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
| BRPI0412343A (pt) | 2003-07-30 | 2006-09-05 | Xenon Pharmaceuticals Inc | derivados de piridazina e seu uso como agentes terapêuticos |
| US7345043B2 (en) | 2004-04-01 | 2008-03-18 | Miikana Therapeutics | Inhibitors of histone deacetylase |
| TW200626138A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| MX2007003327A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa. |
| AR051026A1 (es) * | 2004-09-20 | 2006-12-13 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa |
| US8071603B2 (en) | 2004-09-20 | 2011-12-06 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| WO2006034341A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| MX2007003329A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y biciclicos y su uso como inhibidores de estearoil-coa-desaturasa (scd). |
| CA2580855A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| BRPI0515482A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e seus usos como agentes terapêuticos |
| GT200600046A (es) | 2005-02-09 | 2006-09-25 | Terapia de combinacion | |
| WO2006125181A2 (en) | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Piperidine derivatives and their use as stearoyl-coa desaturase modulators |
| WO2006130986A1 (en) | 2005-06-09 | 2006-12-14 | Merck Frosst Canada Ltd. | Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| CA2615045A1 (en) | 2005-07-20 | 2007-01-25 | Merck Frosst Canada Ltd. | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| AU2006299671A1 (en) | 2005-10-05 | 2007-04-12 | Merck Frosst Canada Ltd | Substituted quinolines as inhibitors of leukotriene biosynthesis |
| EP1951731A4 (en) | 2005-11-15 | 2010-07-07 | Merck Frosst Canada Ltd | AZACYCLOHEXANDERIVATES AS INHIBITORS OF STEAROYL-COENZYME-A-DELTA-9-DESATURASE |
| WO2007071023A1 (en) | 2005-12-20 | 2007-06-28 | Merck Frosst Canada Ltd. | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| CA2651700A1 (en) | 2006-05-22 | 2007-11-29 | Merck Frosst Canada Ltd. | Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| JP2009539884A (ja) | 2006-06-12 | 2009-11-19 | メルク フロスト カナダ リミテツド | ステアロイル−コエンザイムａデルタ−９デサチュラーゼのインヒビターとしてのアゼチジン誘導体 |
| US7754745B2 (en) | 2006-06-13 | 2010-07-13 | Merck Frosst Canada Ltd. | Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| US20090318476A1 (en) | 2006-08-09 | 2009-12-24 | Merck Frosst Canada Ltd. | Azacycloalkane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase |
| WO2008046226A1 (en) | 2006-10-20 | 2008-04-24 | Merck Frosst Canada Ltd. | Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| AR064965A1 (es) | 2007-01-26 | 2009-05-06 | Merck Frosst Canada Inc | Derivados de azacicloalcanos como inhibidores de estearoil - coenzima a delta -9 desaturasa |
-
2007
- 2007-11-26 TW TW096144835A patent/TW200826936A/zh unknown
- 2007-11-28 EA EA200970524A patent/EA200970524A1/ru unknown
- 2007-11-28 WO PCT/CA2007/002139 patent/WO2008064474A1/en not_active Ceased
- 2007-11-28 MX MX2009005713A patent/MX2009005713A/es unknown
- 2007-11-28 AT AT07845603T patent/ATE543816T1/de active
- 2007-11-28 EP EP07845603A patent/EP2099793B1/en active Active
- 2007-11-28 JP JP2009538560A patent/JP5050061B2/ja not_active Expired - Fee Related
- 2007-11-28 CA CA2670703A patent/CA2670703C/en not_active Expired - Fee Related
- 2007-11-28 BR BRPI0719702-0A patent/BRPI0719702A2/pt not_active IP Right Cessation
- 2007-11-28 AU AU2007327276A patent/AU2007327276B2/en not_active Ceased
- 2007-11-28 KR KR1020097013826A patent/KR20090086623A/ko not_active Ceased
- 2007-11-29 AR ARP070105302A patent/AR064026A1/es not_active Application Discontinuation
- 2007-11-29 CL CL200703440A patent/CL2007003440A1/es unknown
- 2007-11-30 PE PE2007001699A patent/PE20081199A1/es not_active Application Discontinuation
- 2007-11-30 US US11/998,501 patent/US8063224B2/en active Active
-
2009
- 2009-05-19 IL IL198824A patent/IL198824A0/en unknown
- 2009-05-27 GT GT200900144A patent/GT200900144A/es unknown
- 2009-05-27 SV SV2009003275A patent/SV2009003275A/es unknown
- 2009-05-28 CO CO09054946A patent/CO6190521A2/es not_active Application Discontinuation
- 2009-05-29 TN TNP2009000212A patent/TN2009000212A1/fr unknown
- 2009-06-01 EC EC2009009375A patent/ECSP099375A/es unknown
- 2009-06-10 CR CR10858A patent/CR10858A/es unknown
- 2009-06-22 MA MA32023A patent/MA31017B1/fr unknown
- 2009-06-30 NO NO20092469A patent/NO20092469L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE543816T1 (de) | 2012-02-15 |
| CL2007003440A1 (es) | 2008-04-04 |
| GT200900144A (es) | 2011-06-23 |
| CA2670703C (en) | 2012-05-15 |
| WO2008064474A1 (en) | 2008-06-05 |
| AU2007327276B2 (en) | 2011-06-09 |
| AU2007327276A1 (en) | 2008-06-05 |
| AR064026A1 (es) | 2009-03-04 |
| MA31017B1 (fr) | 2009-12-01 |
| KR20090086623A (ko) | 2009-08-13 |
| EA200970524A1 (ru) | 2009-12-30 |
| MX2009005713A (es) | 2009-06-08 |
| CA2670703A1 (en) | 2008-06-05 |
| ECSP099375A (es) | 2009-07-31 |
| US8063224B2 (en) | 2011-11-22 |
| TN2009000212A1 (en) | 2010-10-18 |
| JP5050061B2 (ja) | 2012-10-17 |
| CO6190521A2 (es) | 2010-08-19 |
| EP2099793A4 (en) | 2010-12-29 |
| EP2099793B1 (en) | 2012-02-01 |
| CR10858A (es) | 2009-06-25 |
| TW200826936A (en) | 2008-07-01 |
| IL198824A0 (en) | 2010-02-17 |
| EP2099793A1 (en) | 2009-09-16 |
| SV2009003275A (es) | 2009-11-18 |
| BRPI0719702A2 (pt) | 2013-12-17 |
| PE20081199A1 (es) | 2008-10-19 |
| US20080132542A1 (en) | 2008-06-05 |
| JP2010510993A (ja) | 2010-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20092469L (no) | Azasykloalkanderivater som inhibitorer av stearoyl-koenzym A-delta-9-desaturase | |
| NO20073806L (no) | Substituerte pyridinyl og pyrimidinylderivater som modulatorer av metabolisme og behandling av lidelser relatert til dette | |
| BR112012021771A2 (pt) | métodos de uso de inibidores de contransportadores de sódio-glicose 1 e 2. | |
| MX2008013484A (es) | Derivados de lactamas de ciclohexilpirazol como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1. | |
| EA200870474A1 (ru) | Ингибиторы 11-бета-гидроксистероид дегидрогеназы 1 | |
| NO20084278L (no) | Bezothiazol derivatives as beta2 adrenoreceptor agonists | |
| ATE555081T1 (de) | Adamantyl-derivate als inhibitoren des 11-beta- hydroxysteroid-dehydrogenase-1-enzyms | |
| EA200970090A1 (ru) | Модуляторы метаболизма и лечение связанных с ним расстройств | |
| NO20065868L (no) | Substituerte aryl- og heteroarylderivater som metabolisme- og profylkasemodulatorer og behandling av forstyrrelser forbundet med dette | |
| UA98651C2 (ru) | Спироциклы как ингибиторы 11-бета гидроксилстероиддегидрогеназы типа 1 | |
| MA30686B1 (fr) | Inhibiteurs de la 11-beta-hydroxysteroide deshydrogenase. | |
| UA109643C2 (uk) | Арил- і гетероарилкарбонільні похідні гексагідроінденопіридину та октагідробензохіноліну | |
| MX2010001754A (es) | Derivados de azepina como inhibidores de gamma secretasa. | |
| ATE471311T1 (de) | Inhibitoren von11-beta- hydroxysteroiddehydrogenase 1 | |
| UA97257C2 (en) | Indole derivatives | |
| GEP20135724B (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes | |
| MX2009010894A (es) | Derivados de 3-hidroquinazolin-4-ona para utilizarse como inhibidores de estearoil-coa-desaturasa. | |
| CY1113645T1 (el) | Παραγωγα 7-αζαϊνδολης ως επιλεκτικοι αναστολεις 11-βητα-υδροξυστεροειδους δεϋδρογενασης τυπου 1 | |
| DK2364983T3 (da) | Nyt tricyklisk derivat eller farmaceutisk acceptable salte deraf, fremgangsmåde til fremstilling deraf og farmaceutisk sammensætning indeholdende disse | |
| PE20091425A1 (es) | Derivados de aminotiazol | |
| EA201300759A1 (ru) | Новые производные nip тиазола в качестве ингибиторов 11-бета-гидроксистероид дегидрогеназы-1 | |
| EA200970170A1 (ru) | Производные 4-триметиламмоний-3-аминобутирата и 4-триметилфосфоний-3-аминобутирата как ингибиторы срт | |
| GEP20135804B (en) | Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester introduced therein as substituent | |
| EA201100419A1 (ru) | Сопряженные пирролидино-циклопропановые производные в качестве селективных ингибиторов 11-бета-гидроксистероид дегидрогеназы 1 типа | |
| NO20092719L (no) | Nye kromen-2-on-derivater og deres anvendelse som monoaminneurotransmitter-gjenopptaksinhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Reestablishment of rights (par. 72 patents act) | ||
| FC2A | Withdrawal, rejection or dismissal of laid open patent application | ||
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |